trial · primary record
CMV Cytotoxic T-Lymphocytes
Congenital Cytomegaloviral (CMV) Disease
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 23 |
| Primary completion | 2028-10-31 |
| Primary endpoint | To determine the safety of giving CMV CTLs combined with anti-viral therapy in neonates with CMV |
| Registry ID | NCT05564598 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:38.653Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05564598
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.